Diagnosis and management of HIV-associated neuropathy.
Distal sensory polyneuropathy (DSP) is the most common neurologic complication of HIV infection and a major cause of morbidity in HIV-infected patients. DSP may occur secondary to HIV (HIV-DSP) or be due to antiretroviral drug toxicity. Timely detection of the symptoms and signs of DSP in patients who have HIV may allow for the reversal of the toxic effects of antiretrovirals and for the initiation of symptomatic treatment. The pathogenic mechanism of HIV-DSP is likely multifactorial. Restorative therapies for DSP are not currently available but recent advances have led to novel symptomatic therapies. This article highlights the risk factors, pathogenesis, pathology, clinical features, diagnostic studies, differential diagnosis, and treatment of HIV-associated neuropathy.
Gonzalez-Duarte
Alejandra
A
The Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1187, New York, NY 10029-6574, USA.
Robinson-Papp
Jessica
J
Simpson
David M
DM
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018925:Chemokines / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D003937:Diagnosis, Differential; D016049:Didanosine / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D054303:HIV Reverse Transcriptase / Q000627:therapeutic use*; D006801:Humans; D008264:Macrophages / Q000502:physiology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000821:virology*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011788:Quality of Life / Q000523:psychology
D044966:Anti-Retroviral Agents; D018925:Chemokines; D016207:Cytokines; D011480:Protease Inhibitors; D054303:HIV Reverse Transcriptase; D016049:Didanosine